Image 01 Image 03

Wuhan Coronavirus Tag

Pfizer and BioNTech found its COVID-19 is 95% effective in the last trial run, "meeting all primary efficacy endpoints." The vaccine also showed signs of safety and met all the requirements for the FDA to approve its use as soon as possible.